91 Prevention of rheumatoid arthritis 67 Chodick G, Amital H, Shalem Y, Kokia E, Heymann AD, Porath A, Shalev V. 2010; Persistence with statins and onset of rheumatoid arthritis: a population-based cohort study. PLoS Med. 7(9):e1000336. 68 van Boheemen L, Turk S, Beers-Tas M V, Bos W, Marsman D, Griep EN, Starmans-Kool M, Popa CD, van Sijl A, Boers M, Nurmohamed MT, van Schaardenburg D. 2021; Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial. RMD Open. 7(1). 69 2015. Trial registration: Statins to Prevent Rheumatoid Arthritis (STAPRA) [Internet]. 70 Mosor E, Stoffer-Marx M, Steiner G, Raza K, Stack RJ, Simons G, Falahee M, Skingle D, Dobrin M, Schett G, Englbrecht M, Smolen JS, Kjeken I, Hueber AJ, Stamm TA. 2020; I Would Never Take Preventive Medication! Perspectives and Information Needs of People Who Underwent Predictive Tests for Rheumatoid Arthritis. Arthritis Care Res. 72(3):360–8. 71 Finckh A, Escher M, Liang MH, Bansback N. 2016; Preventive Treatments for Rheumatoid Arthritis: Issues Regarding Patient Preferences. Curr Rheumatol Rep. 18(8):51. 72 van Boheemen L, Bolt JW, Ter Wee MM, de Jong HM, van de Sande MG, van Schaardenburg D. 2020; Patients’ and rheumatologists’ perceptions on preventive intervention in rheumatoid arthritis and axial spondyloarthritis. Arthritis Res Ther. 22(1):217. 73 Falahee M, Finckh A, Raza K, Harrison M. 2019; Preferences of Patients and At-risk Individuals for Preventive Approaches to Rheumatoid Arthritis. Clin Ther. 41(7):1346–54. 74 Harrison M, Bansback N, Aguiar M, Koehn C, Shojania K, Finckh A, Hudson M. 2020; Preferences for treatments to prevent rheumatoid arthritis in Canada and the influence of shared decision-making. Clin Rheumatol. 39(10):2931–41. 75 van Boheemen L, Ter Wee MM, Seppen B, van Schaardenburg D. 2021; How to enhance recruitment of individuals at risk of rheumatoid arthritis into trials aimed at prevention: understanding the barriers and facilitators. RMD Open. 7(1). 76 Studenic P, Hensvold A, Kleyer A, van der Helm-van Mil A, Pratt AG, Sieghart D, Kronke G, Williams R, de Souza S, Karlfeldt S, Johannesson M, Krogh NS, Klareskog L, Catrina AI. 2022; Prospective Studies on the Risk of Rheumatoid Arthritis: The European Risk RA Registry. Front Med. 9:824501. 77 Alpizar-Rodriguez D, Finckh A. 2020; Is the prevention of rheumatoid arthritis possible? Clin Rheumatol. 39(5):1383–9. 78 van der Helm-van Mil A, Landewe RBM. 2020; The earlier, the better or the worse? Towards accurate management of patients with arthralgia at risk for RA. Ann Rheum Dis. 79(3):312–5. 79 Isaacs J, Iqbal K. 2019; Potential Pharmacologic Targets for the Prevention of Rheumatoid Arthritis. Clin Ther. 4
RkJQdWJsaXNoZXIy MTk4NDMw